CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 30 of 48

Rheumatology (Oxford)

Briefs 1,161–1,200 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Pain is common in myositis and associated with disease activity

    Cohort studyMyositis

  2. Rheumatology (Oxford)

    Comparing clinical features between males and females with VEXAS syndrome: data from literature analysis of patient reports

    Meta-analysisAutoinflammatory & rare

  3. Rheumatology (Oxford)

    Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up

    Cohort studyLupus & APS

  4. Rheumatology (Oxford)

    Remote monitoring of patients with rheumatoid arthritis in a low disease activity state: a mixed methods evaluation across six hospitals in London, UK

    Cross-sectional studyRA

  5. Rheumatology (Oxford)

    Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective study

    Cohort studyLupus & APS

  6. Rheumatology (Oxford)

    Interleukin-6 trans-signalling regulates monocyte chemoattractant protein-1 production in immune-mediated necrotizing myopathy

    Mechanistic studyMyositis

  7. Rheumatology (Oxford)

    Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings

    Cohort studySpondyloarthritis & PsA

  8. Rheumatology (Oxford)

    Well-Being Therapy in systemic sclerosis outpatients: a randomized controlled trial

    Randomized controlled trialSystemic sclerosis

  9. Rheumatology (Oxford)

    Anti-carbamylated protein antibodies drive AEC II toward a profibrotic phenotype by interacting with carbamylated TLR5

    Mechanistic studyRA

  10. Rheumatology (Oxford)

    The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials

    Meta-analysisRA

  11. Rheumatology (Oxford)

    Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies

    Meta-analysisSpondyloarthritis & PsA

  12. Rheumatology (Oxford)

    Comparative effectiveness of tofacitinib and tumour necrosis factor inhibitors in patients with rheumatoid arthritis in real-world practice: a prospective observational study

    Cohort studyRA

  13. Rheumatology (Oxford)

    Follow-up ultrasound examination in patients with newly diagnosed giant cell arteritis

    Cohort studyVasculitis & PMR

  14. Rheumatology (Oxford)

    Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis

    Cohort studySystemic sclerosis

  15. Rheumatology (Oxford)

    A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: a STARTER study post-hoc analysis

    Secondary analysisRA

  16. Rheumatology (Oxford)

    Disease activity–guided dose optimization including discontinuation of TNF inhibitors in rheumatoid arthritis is effective for up to 10 years: an observational follow-up of the DRESS study

    Randomized controlled trialRA

  17. Rheumatology (Oxford)

    Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis

    Secondary analysisSpondyloarthritis & PsA

  18. Rheumatology (Oxford)

    The one-year infection risk among patients diagnosed with giant cell arteritis: use of antibiotics and hospitalisations

    Cohort studyVasculitis & PMR

  19. Rheumatology (Oxford)

    Are gout patients with negative dual-energy computed tomography for monosodium urate crystal deposition easy to treat?

    Cohort studyGout & crystals

  20. Rheumatology (Oxford)

    Cardiac involvement in eosinophilic granulomatosis with polyangiitis: acute eosinophilic myocarditis and chronic inflammatory cardiomyopathy

    Cohort studyVasculitis & PMR

  21. Rheumatology (Oxford)

    Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

    Cohort studyVasculitis & PMR

  22. Rheumatology (Oxford)

    Lung imaging patterns in connective tissue disease–associated interstitial lung disease impact prognosis and immunosuppression response

    Cohort studySystemic sclerosis

  23. Rheumatology (Oxford)

    Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials

    Secondary analysisSpondyloarthritis & PsA

  24. Rheumatology (Oxford)

    Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis

    Cohort studyPediatric

  25. Rheumatology (Oxford)

    Fragmented QRS complex could predict all-cause mortality in patients with connective tissue disease–associated pulmonary arterial hypertension

    Cohort studySystemic sclerosis

  26. Rheumatology (Oxford)

    Serum protein profiling reveals distinct patient clusters in giant cell arteritis

    Mechanistic studyVasculitis & PMR

  27. Rheumatology (Oxford)

    The information required by people with inflammatory arthritis when taking Methotrexate: a mixed-methods systematic review

    Meta-analysisRA

  28. Rheumatology (Oxford)

    Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials

    Meta-analysisSpondyloarthritis & PsA

  29. Rheumatology (Oxford)

    Identification of the VLDLR locus associated with giant cell arteritis and the possible causal role of low-density lipoprotein cholesterol in its pathogenesis

    Meta-analysisVasculitis & PMR

  30. Rheumatology (Oxford)

    Preliminary nomogram model for predicting irreversible organ damage of patients with systemic sclerosis

    Cohort studySystemic sclerosis

  31. Rheumatology (Oxford)

    Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis

    Cohort studyRA

  32. Rheumatology (Oxford)

    Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study

    Cohort studyRA

  33. Rheumatology (Oxford)

    Patient-reported outcome for physical function in idiopathic inflammatory myopathy

    Cohort studyMyositis

  34. Rheumatology (Oxford)

    Seven-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls

    Cohort studyLupus & APS

  35. Rheumatology (Oxford)

    Arthroplasty rates and risk in familial Mediterranean fever patients: a large population-based study

    Cohort studyAutoinflammatory & rare

  36. Rheumatology (Oxford)

    Revealing novel genomic insights and therapeutic targets for juvenile idiopathic arthritis through omics

    Meta-analysisPediatric

  37. Rheumatology (Oxford)

    Susceptibility to mycobacterial infection in VEXAS syndrome

    Cohort studyAutoinflammatory & rare

  38. Rheumatology (Oxford)

    Very-low-dose glucocorticoid therapy in rheumatoid arthritis: impact of b/tsDMARDs initiation timing on glucocorticoid withdrawal

    Cohort studyRA

  39. Rheumatology (Oxford)

    A systematic review of patient-reported outcome measures in patients with anti-neutrophil cytoplasmic antibody associated vasculitis

    Meta-analysisVasculitis & PMR

  40. Rheumatology (Oxford)

    Associations between plasma metabolism-associated proteins and future development of giant cell arteritis: results from a prospective study

    Case-control studyVasculitis & PMR

All 1,905 Briefs in ExploreShowing Briefs 1,161–1,200 of 1,905, newest first